Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-08-000973
Filing Date
2008-04-15
Accepted
2008-04-15 13:37:18
Documents
13
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 zk84904.htm 10-K 285046
2 GRAPHIC agn.gif GRAPHIC 1708
3 GRAPHIC ey_full.jpg GRAPHIC 4496
4 GRAPHIC nexgen.jpg GRAPHIC 4843
5 GRAPHIC pnc.gif GRAPHIC 2265
6 GRAPHIC sig.gif GRAPHIC 2675
7 exhibit_23-1.htm EX-23.1 2067
8 GRAPHIC e-y.jpg GRAPHIC 4893
9 exhibit_23-2.htm EX-23.2 2775
10 exhibit_31-1.htm EX-31.1 4539
11 exhibit_31-2.htm EX-31.2 4517
12 exhibit_32-1.htm EX-32.1 2502
13 exhibit_32-2.htm EX-32.2 2480
  Complete submission text file 0001178913-08-000973.txt   335258
Mailing Address 32 HASHAHAM ST. P.O.B. 7805 PETACH TIKVA L3 49170
Business Address 2533 WINDGUARD CIRCLE, SUITE 102 WESLEY CHAPEL FL 33544 011-972-3-9277232
NEXGEN BIOFUELS LTD (Filer) CIK: 0000835688 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-17788 | Film No.: 08756683
SIC: 2835 In Vitro & In Vivo Diagnostic Substances